PTJ
EVH icon

Paul Tudor Jones’s Evolent Health EVH Stock Holding History

Paul Tudor Jones’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-11,600
Closed -$131K – 3236
2024
Q4 		$131K Buy
+11,600
New +$204K ﹤0.01% 2895
2022
Q4 		– Sell
-5,700
Closed -$206K – 2513
2022
Q3 		$206K Buy
+5,700
New +$201K ﹤0.01% 2051

Other funds holding EVH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CCM
Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
RF
Rubicon Founders Nashville, Tennessee $196M AUM 53.12% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $327M AUM 22.96% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Paul Tudor Jones's EVH Position: Q2 2026 in Review

Paul Tudor Jones increased its Evolent Health (EVH) stake by 580% in Q2 2026, buying an estimated $2.29M and bringing the position to 699,267 shares worth $3.79M. The position accounts for 0.01% of the portfolio, ranked #1479.

Paul Tudor Jones first reported a position in EVH in Q2 2015 and has held it in 19 quarters since. The position peaked at $13.8M in Q1 2024. 198 funds tracked by Wall St. Rank hold EVH as of Q2 2026.

  • Paul Tudor Jones held 699,267 shares of Evolent Health worth $3.79M as of Q2 2026.
  • Paul Tudor Jones bought 596,400 Evolent Health shares in Q2 2026, an estimated $2.29M.
  • Evolent Health made up 0.01% of Paul Tudor Jones's portfolio in Q2 2026, its #1479 holding.
  • Paul Tudor Jones first reported a position in Evolent Health in Q2 2015 and has held it in 19 quarters since.
  • Paul Tudor Jones's Evolent Health position peaked at $13.8M in Q1 2024.
  • 198 funds tracked by Wall St. Rank held Evolent Health as of Q2 2026.

Based on Tudor Investment Corp's 13F filing for Q2 2026, filed 14 Aug 2026.